| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |